0930 GMT - DSM-Firmenich could launch another share buyback program in 2026, analysts at Equita write. This follows the nutrition, health and bioscience company announcing a surprise 1 billion euro buyback alongside its fourth-quarter results. The buyback launched on Thursday will be executed over the next 12 months and is valued at 3.7% of its market capitalization, they write. The buyback follows solid fourth-quarter results, which were slightly better than expected, the analysts write. Shares trade up 2.62% at 103.65 euros. (adam.whittaker@wsj.com)
(END) Dow Jones Newswires
February 13, 2025 04:31 ET (09:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.